MoneyWorks4Me

Dr. Reddy’s Laboratories submits press release

03 Jul 2019 Evaluate

Dr. Reddy’s Laboratories has informed about submission of a press release on ‘Dr. Reddy's Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (lmL) Single-dose Vial in the US Market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..